Jane Street’s Opus Genetics IRD Stock Holding History

Jane Street’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$719K	Buy	+158,103	New	+$547K	﹤0.01%	7219
2025 Q1	–	Sell	-18,353	Closed	-$21.8K	–	10974
2024 Q4	$21.8K	Buy	+18,353	New	+$21.1K	﹤0.01%	9121
2024 Q3	–	Sell	-42,375	Closed	-$64.8K	–	10595
2024 Q2	$64.8K	Buy	+42,375	New	+$73.2K	﹤0.01%	8864
2024 Q1	–	Sell	-34,691	Closed	-$104K	–	10246
2023 Q4	$104K	Buy	+34,691	New	+$103K	﹤0.01%	8561
2021 Q3	–	Sell	-24,984	Closed	-$132K	–	10895
2021 Q2	$132K	Buy	+24,984	New	+$124K	﹤0.01%	9133
2019 Q1	–	Sell	-277	Closed	-$12K	–	5758
2018 Q4	$12K	Buy	+277	New	+$16.2K	﹤0.01%	4817
2018 Q3	–	Sell	-276	Closed	-$19K	–	5823
2018 Q2	$19K	Buy	+276	New	+$24.3K	﹤0.01%	4869

Other funds holding IRD

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jane Street's IRD Position: Q1 2026 in Review

Jane Street opened a new position in Opus Genetics (IRD) in Q1 2026: 158,103 shares worth $719K. The stake represents ﹤0.01% of the portfolio and ranks #7219 among its holdings. This is a return to the name: Jane Street previously reported a position in IRD as recently as Q4 2024.

Jane Street first reported a position in IRD in Q2 2018 and has held it in 7 quarters since. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

Jane Street held 158,103 shares of Opus Genetics worth $719K as of Q1 2026.
Opus Genetics was a new Jane Street position in Q1 2026.
Opus Genetics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7219 holding.
Jane Street first reported a position in Opus Genetics in Q2 2018 and has held it in 7 quarters since.
79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.